KMTS · Kestra Medical Technologies, Ltd.
$26.99
-0.27 (-0.99%)
At close · Aug 21
Market Cap
$1.58B
Shares
58.60M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$95.13M
+59%
FY2026
Net Income
-$131.61M
-15.6%
FY2026
Gross Margin
51.37%
+10.9pp
FY2026
Operating Margin
-141.64%
+36.2pp
FY2026
Diluted EPS
-$2.43
+52.6%
FY2026
Operating Cash Flow
-$81.7M
-5.3%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2027 (G) | FY2026 | FY2025 | FY2024 |
|---|---|---|---|---|
| $137M | $95.13MG | $59.82M | $27.81M | |
| — | $46.26M | $35.61M | $27.45M | |
| — | $48.86M | $24.21M | $362K | |
| — | 51.37% | 40.47% | 1.3% | |
| — | $19.48M | $15.65M | $15.49M | |
| — | $164.12M | $114.94M | $69.94M | |
| — | $8.71M | $7.97M | $11.56M | |
| — | $183.6M | $130.59M | $85.43M | |
| — | -$134.74M | -$106.38M | -$85.06M | |
| — | -141.64% | -177.85% | -305.83% | |
| — | -$126.03M | -$98.41M | -$73.5M | |
| — | $7.55M | $7.73M | $6.23M | |
| — | $8.35M | $3.2M | — | |
| — | $2.62M | -$2.77M | -$2.8M | |
| — | $0 | $0 | — | |
| — | -$131.32M | -$113.68M | -$94.1M | |
| — | $294K | $135K | $24K | |
| — | -$131.61M | -$113.81M | -$94.12M | |
| — | -138.36% | -190.28% | -338.39% | |
| — | -$131.61M | -$126.14M | -$100.84M | |
| — | -$131.83M | -$113.81M | — | |
| USD/shares | — | -$2.43 | -$5.13 | -$5.07 |
| USD/shares | — | -$2.43 | -$5.13 | -$5.07 |
| shares | — | 54.18M | 24.58M | 19.89M |
| shares | — | 54.18M | 24.58M | 19.89M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
(G): the company's own guidance — a (G) column is a guided period not yet reported; a G marker shows how the reported figure landed against the guided range. Non-GAAP-basis guidance (*) is shown as stated and never judged against GAAP actuals.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
15.01×
Peer median 2.74×
EV/EBIT
—
Peer median 33.65×
P/E (TTM)
—
Peer median 30.30×
Peer medians compare against the 27 similar-size Medical Instruments & Supplies companies (of 46 listed).
Valuation over time computed as of each quarter's filing date
Key facts
CIK
1877184
CUSIP
G52441105
13F (30d)
97 filings
96 filers
Visit website
Investor relations